Caxton Associates (UK)’s Abbott ABT Stock Holding History

Caxton Associates (UK)’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,827	Closed	-$290K	–	732
2026 Q1	$290K	Buy	+2,827	New	+$319K	0.01%	615

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Caxton Associates (UK)'s ABT Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Abbott (ABT) in Q2 2026, closing a stake of 2,827 shares — an estimated $290K sold.

Caxton Associates (UK) first reported a position in ABT in Q1 2026 and held it in 1 quarter. The position peaked at $290K in Q1 2026. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Caxton Associates (UK) reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Caxton Associates (UK) sold 2,827 Abbott shares in Q2 2026, an estimated $290K.
Caxton Associates (UK) first reported a position in Abbott in Q1 2026 and held it in 1 quarter.
Caxton Associates (UK)'s Abbott position peaked at $290K in Q1 2026.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.